NasdaqGS - Delayed Quote USD
Rallybio Corporation (RLYB)
At close: 4:00 PM EDT
After hours: 4:58 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.68M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| LIEBER JONATHAN I Chief Financial Officer | Purchase at price 5.21 per share. | Direct | 26,050 | Mar 14, 2023 |
| PARMAR KUSH M Director | Sale at price 8.20 per share. | Indirect | 820,000 | Mar 7, 2023 |
| 5AM VENTURES V, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 8.20 per share. | Indirect | 820,000 | Mar 7, 2023 |
Related Tickers
IKNA Ikena Oncology, Inc.
1.6900
-1.17%
GLUE Monte Rosa Therapeutics, Inc.
5.45
-1.27%
XLO Xilio Therapeutics, Inc.
0.8092
+3.88%
TNYA Tenaya Therapeutics, Inc.
1.9200
-5.88%
TSBX Turnstone Biologics Corp.
0.5280
+9.77%
LYEL Lyell Immunopharma, Inc.
1.1200
-4.27%
IPSC Century Therapeutics, Inc.
1.5400
-3.75%
DSGN Design Therapeutics, Inc.
5.60
+0.09%
OVID Ovid Therapeutics Inc.
1.1900
-2.46%
PASG Passage Bio, Inc.
0.5885
+1.55%